Clinical Trial Update: The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating sildenafil for preterm infants with evolving chronic lung disease (bronchopulmonary dysplasia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Lung Disease of Prematurity

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Mercy Hospital for Women, Australia | Conditions: Lung Diseases | Phase 3 | Status: COMPLETED